Antipancreatic cancer effect of DNT cells and the underlying mechanism

Pancreatology. 2019 Jan;19(1):105-113. doi: 10.1016/j.pan.2018.12.006. Epub 2018 Dec 15.

Abstract

Objectives: This study aimed to explore double-negative T (DNT) cell cytotoxicity to pancreatic cancer and the effect of the Fas (CD95, APO-1)/FasL (CD178) signaling pathway on this process.

Methods: DNT cells from the peripheral blood of healthy volunteers were expanded in vitro. The inhibitory effect of DNT cells on pancreatic cancer cells was investigated using a CCK-8 assay and nude mouse tumor model. A mechanistic study was performed using pathway blocking assays.

Results: DNT cells were amplified in vitro with >90% purity, and the growth of pancreatic cancer in vitro was significantly inhibited by DNT cells. After coculture with DNT cells, Fas, caspase-8 and cleaved caspase-8 showed increased expression in pancreatic cancer cells. When blocking agent decoy receptor 3 (DcR3) was added, the antitumor effect of DNT cells and the expression of Fas, caspase-8 and cleaved caspase-8 were reduced in pancreatic cancer cells. In the nude mouse tumor model, the tumor volume and weight were lower in the DNT cell group and gemcitabine group than in the blank control group. Additionally, the expression of Fas, caspase-8 and cleaved caspase-8 was higher in the DNT cell group than in the blank control group. Moreover, DNT cells promoted apoptosis in cancer cells and animal model tissues.

Conclusion: DNT cells inhibited the growth of pancreatic cancer, and the Fas/FasL signaling pathway was involved in this process.

Keywords: DNT cell; Fas; FasL; Pancreatic cancer.

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Cell Line
  • Cell Transplantation
  • Coculture Techniques
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Fas Ligand Protein
  • Gemcitabine
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasms, Experimental
  • Pancreatic Neoplasms / therapy*
  • T-Lymphocyte Subsets*
  • fas Receptor

Substances

  • Antineoplastic Agents
  • FAS protein, human
  • Fas Ligand Protein
  • fas Receptor
  • Deoxycytidine
  • Gemcitabine